The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Repurposing High-Throughput Image Assays Enables Biological Activity Prediction for Drug Discovery
Open accessAbstract
SUMMARY In both academia and the pharmaceutical industry, large-scale assays for drug discovery are expensive and often impractical, particularly for the increasingly important physiologically relevant model systems that require primary cells, organoids, whole organisms, or expensive or rare reagents. We hypothesized that data from a single high-throughput imaging assay can be repurposed to predict the biological activity of compounds in other assays, even those targeting alternate pathways or biological processes. Indeed, quantitative information extracted from a three-channel microscopy-based screen for glucocorticoid receptor translocation was able to predict assay-specific biological activity in two ongoing drug discovery projects. In these projects, repurposing increased hit rates by 60- to 250-fold over that of the initial project assays while increasing the chemical structure diversity of the hits. Our results suggest that data from high-content screens are a rich source of information that can be used to predict and replace customized biological assays.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
Caruana, R. (1997) · Machine Learning · doi:10.1023/a:1007379606734 · Cited by 6,636
DeepTox: toxicity prediction using deep learning
Mayr, A., Klambauer, G., Unterthiner, T., & Hochreiter, S. (2016) · Frontiers in Environmental Science · doi:10.3389/fenvs.2015.00080 · Cited by 1,081
Self-citationUnderstanding Random Forests: From Theory to Practice
Louppe, G. (2014) · arXiv · doi:10.48550/arxiv.1407.7502 · Cited by 693
Multiplex Cytological Profiling Assay to Measure Diverse Cellular States
Gustafsdottir, S. M., Ljosa, V., Sokolnicki, K. L., Anthony Wilson, J., Walpita, D., Kemp, M. M., Petri Seiler, K., Carrel, H. A., Golub, T. R., Schreiber, S. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080999 · Cited by 291
Self-citationWawer, M. J., Li, K., Gustafsdottir, S. M., Ljosa, V., Bodycombe, N. E., Marton, M. A., Sokolnicki, K. L., Bray, M.-A., Kemp, M. M., Winchester, E., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410933111 · Cited by 196 · cited 1×
“While a few efforts have publicly documented up to about 30,000 compounds with cellular images (Wawer et al., 2014), only a 10th of the compounds have been annotated with some assay activities, yielding a very sparse annotation matrix.”
BackgroundSelf-citationAnsbro, M. R., Shukla, S., Ambudkar, S. V., Yuspa, S. H., & Li, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060334 · Cited by 54
Deep Big Multilayer Perceptrons for Digit Recognition
Cireşan, D. C., Meier, U., Gambardella, L. M., & Schmidhuber, J. (2012) · Lecture Notes in Computer Science · doi:10.1007/978-3-642-35289-8_31 · Cited by 48
Cited by
Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473
“Similarly, using DeepTox, Simm et al. 2018 analyzed and repurposed high-throughput imaging assay data to predict the biological activity of different chemical compounds that were targeting alternative biological pathways and processes [338].”
MethodDeep learning for cellular image analysis
Moen, E., Bannon, D., Kudo, T., Graf, W., Covert, M., & Van Valen, D. (2019) · Nature Methods · doi:10.1038/s41592-019-0403-1 · Cited by 1,225
Data-analysis strategies for image-based cell profiling
Caicedo, J. C., Cooper, S., Heigwer, F., Warchal, S., Qiu, P., Molnar, C., Vasilevich, A. S., Barry, J. D., Bansal, H. S., Kraus, O., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4397 · Cited by 739
Self-citationDeepSynergy: predicting anti-cancer drug synergy with Deep Learning
Preuer, K., Lewis, R. P. I., Hochreiter, S., Bender, A., Bulusu, K. C., & Klambauer, G. (2018) · Bioinformatics · doi:10.1093/bioinformatics/btx806 · Cited by 653
Self-citationArtificial intelligence in drug development
Zhang, K., Yang, X., Wang, Y., Yu, Y., Huang, N., Li, G., Li, X., Wu, J. C., & Yang, S. (2025) · Nature Medicine · doi:10.1038/s41591-024-03434-4 · Cited by 498
Bender, A., & Cortés-Ciriano, I. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.12.009 · Cited by 405
Image-based profiling for drug discovery: due for a machine-learning upgrade?
Chandrasekaran, S. N., Ceulemans, H., Boyd, J. D., & Carpenter, A. E. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00117-w · Cited by 389
Self-citationTarget identification among known drugs by deep learning from heterogeneous networks
Zeng, X., Zhu, S., Lu, W., Liu, Z., Huang, J., Zhou, Y., Fang, J., Huang, Y., Guo, H., Li, L., et al. (2020) · Chemical Science · doi:10.1039/c9sc04336e · Cited by 357
Phenotypic drug discovery: recent successes, lessons learned and new directions
Vincent, F., Nueda, A., Lee, J., Schenone, M., Prunotto, M., & Mercola, M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00472-w · Cited by 348
Machine and deep learning approaches for cancer drug repurposing
Issa, N. T., Stathias, V., Schürer, S., & Dakshanamurthy, S. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.12.011 · Cited by 274
The evolving role of investigative toxicology in the pharmaceutical industry
Pognan, F., Beilmann, M., Boonen, H. C. M., Czich, A., Dear, G., Hewitt, P., Mow, T., Oinonen, T., Roth, A., Steger-Hartmann, T., et al. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00633-x · Cited by 255
Looking beyond the hype: applied AI and machine learning in translational medicine
Toh, T. S., Dondelinger, F., & Wang, D. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.027 · Cited by 159
Nyffeler, J., Willis, C., Harris, F. R., Foster, M. J., Chambers, B., Culbreth, M., Brockway, R. E., Davidson-Fritz, S., Dawson, D., Shah, I., et al. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116513 · Cited by 67
Proteochemometrics – recent developments in bioactivity and selectivity modeling
Bongers, B. J., IJzerman, A. P., & Van Westen, G. J. P. (2019) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2020.08.003 · Cited by 54
Reliable Prediction Errors for Deep Neural Networks Using Test-Time Dropout
Cortés-Ciriano, I., & Bender, A. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00297 · Cited by 51
Trapotsi, M.-A., Mouchet, E., Williams, G., Monteverde, T., Juhani, K., Turkki, R., Miljković, F., Martinsson, A., Mervin, L., Pryde, K. R., et al. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00076 · Cited by 51
Assessing the performance of the Cell Painting assay across different imaging systems
Tromans‐Coia, C., Jamali, N., Abbasi, H. S., Giuliano, K. A., Hagimoto, M., Jan, K., Kaneko, E., Letzsch, S., Schreiner, A., Sexton, J. Z., et al. (2023) · Cytometry Part A · doi:10.1002/cyto.a.24786 · Cited by 24
Self-citationUnleashing the potential of cell painting assays for compound activities and hazards prediction
Odje, F., Meijer, D., von Coburg, E., van der Hooft, J. J. J., Dunst, S., Medema, M. H., & Volkamer, A. (2024) · Frontiers in Toxicology · doi:10.3389/ftox.2024.1401036 · Cited by 11
Optimizing the Cell Painting assay for image-based profiling
Cimini, B. A., Chandrasekaran, S. N., Kost-Alimova, M., Miller, L., Goodale, A., Fritchman, B., Byrne, P., Garg, S., Jamali, N., Logan, D. J., et al. (2023) · Nature Protocols · doi:10.1038/s41596-023-00840-9 · Cited by 177
Self-citation
Metadata
- Authors
- Simm, J., Klambauer, G., Arany, A., Steijaert, M., Wegner, J. K., Gustin, E., Chupakhin, V., Chong, Y. T., Vialard, J., Buijnsters, P., Velter, I., Vapirev, A., Singh, S., Carpenter, A. E., Wuyts, R., Hochreiter, S., Moreau, Y., & Ceulemans, H.
- Venue
- Cell Chemical Biology
- Publisher
- Elsevier BV
- Published
- 2018-05
- Volume
- 25
- Issue
- 5
- Pages
- 611-618.e3
- ISSN
- 2451-9448 (ISSN-L)
- 2451-9456
- OpenAlex
- W2794301983
- Cited by
- 232
- References
- 8
- FWCI
- 20.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.